In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a EPCLUSA Drug Master File in Korea (EPCLUSA KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of EPCLUSA. The MFDS reviews the EPCLUSA KDMF as part of the drug registration process and uses the information provided in the EPCLUSA KDMF to evaluate the safety and efficacy of the drug.
After submitting a EPCLUSA KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their EPCLUSA API can apply through the Korea Drug Master File (KDMF).
click here to find a list of EPCLUSA suppliers with KDMF on PharmaCompass.